Gary Owens Biography and Net Worth

CEO of Mesa Laboratories

Gary Owens joined Mesa in March of 2017 as Mesa’s Chief Operating Officer (COO), and then was promoted to the role of President and Chief Executive Officer (CEO) in September of the same year. Mr. Owens had previously worked for the Danaher Corporation, joining the multi-billion dollar global science and technology innovator in 2006. At Danaher, he held various VP positions with responsibility for acquiring and integrating a number of new companies as well as leading portions of Beckman Coulter Life Sciences as General Manager. Prior to that, Gary worked in the technology field successfully overseeing the development of several software product lines while expanding sales channels and networks. Mr. Owens received his Bachelor of Science in Engineering degree from Tulane University and his MBA from the Columbia Business School.

What is Gary M. Owens' net worth?: The estimated net worth of Gary M. Owens is at least $4.39 million as of June 16th, 2025. Mr. Owens owns 45,824 shares of Mesa Laboratories stock worth more than $4,391,772 as of April 10th. This net worth evaluation does not reflect any other assets that Mr. Owens may own. Learn More about Gary M. Owens' net worth.
How do I contact Gary M. Owens?: The corporate mailing address for Mr. Owens and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on Gary M. Owens' contact information.
Has Gary M. Owens been buying or selling shares of Mesa Laboratories?: Gary M. Owens has not been actively trading shares of Mesa Laboratories during the last quarter. Most recently, Gary M. Owens sold 1,939 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $97.12, for a transaction totalling $188,315.68. Following the completion of the sale, the chief executive officer now directly owns 45,824 shares of the company's stock, valued at $4,450,426.88. Learn More on Gary M. Owens' trading history.
Who are Mesa Laboratories' active insiders?: Mesa Laboratories' insider roster includes Brian Archbold (SVP), Mark Capone (Director), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), John Sullivan (Director), and R Tripeny (Director). Learn More on Mesa Laboratories' active insiders.
Are insiders buying or selling shares of Mesa Laboratories?: During the last twelve months, Mesa Laboratories insiders bought shares 3 times. They purchased a total of 6,116 shares worth more than $452,076.35. During the last twelve months, insiders at the medical instruments supplier sold shares 3 times. They sold a total of 3,053 shares worth more than $296,507.36. The most recent insider tranaction occured on March, 10th when Director Mark Christopher Capone bought 1,301 shares worth more than $99,331.35. Insiders at Mesa Laboratories own 4.9% of the company. Learn More about insider trades at Mesa Laboratories.
Information on this page was last updated on 3/10/2026.

Gary M. Owens Insider Trading History at Mesa Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2025	Sell	1,939	$97.12	$188,315.68	45,824
3/19/2025	Sell	21,000	$123.91	$2,602,110.00	43,337
10/28/2024	Sell	2,518	$113.62	$286,095.16	45,888
9/1/2023	Sell	2,000	$142.82	$285,640.00	30,032
6/21/2022	Sell	1,756	$188.22	$330,514.32	21,640
6/16/2021	Sell	6,545	$255.67	$1,673,360.15	24,941
6/7/2021	Sell	1,350	$264.00	$356,400.00	8,513
10/8/2020	Sell	1,000	$275.62	$275,620.00	10,186
10/6/2020	Sell	1,000	$265.00	$265,000.00	10,863

Gary M. Owens Buying and Selling Activity at Mesa Laboratories

Mesa Laboratories Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Today's Range

Now: $95.84

$92.40

$96.30

50 Day Range

MA: $88.22

$73.23

$96.57

2 Week Range

Now: $95.84

$55.45

$131.20

Volume

77,739 shs

Average Volume

112,545 shs

Market Capitalization

$529.52 million

P/E Ratio

149.75

Dividend Yield

0.68%

Beta

0.9